Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Smith

Showing results (341-350 of 408) with videos related to

Pageof 41
Sort By:
The Patient|May 11, 2021
Correction to: Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference StudyA Cecilia Jimenez-Moreno, Eline van Overbeeke, Cathy Anne Pinto, et al.
The Lancet. Oncology|October 25, 2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-upMeredith M Regan, Patrick Neven, Anita Giobbie-Hurder, et al.
Scientific Reports|March 3, 2016
N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and NeprilysinA Ian Smith, Niwanthi W Rajapakse, Oded Kleifeld, et al.
Nature Communications|July 7, 2023
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancersEugene F Schuster, Elena Lopez-Knowles, Anastasia Alataki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in SequenceJacquie H Chirgwin, Anita Giobbie-Hurder, Alan S Coates, et al.
Scientific Reports|April 23, 2016
Corrigendum: N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and NeprilysinA Ian Smith, Niwanthi W Rajapakse, Oded Kleifeld, et al.
Zookeys|February 5, 2019
Acari of CanadaFrédéric Baulieu, Wayne Knee, Victoria Nowell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) TrialIan Smith, Denise Yardley, Howard Burris, et al.
Neurosurgical Review|January 8, 2026
Comparison of two novel options for resuspension of inverted U-shaped nasopharyngeal flap following endonasal access to cranio-vertebral junction: Pilot cadaveric analysis and illustrative case reportBeatrice Zucca, Marissa Koscielski, John Na, et al.
Nature Communications|October 5, 2021
Orchestrating and sharing large multimodal data for transparent and reproducible researchAnthony Mammoliti, Petr Smirnov, Minoru Nakano, et al.
Pageof 41

Showing results (341-350 of 408) with videos related to

Sort By:
Pageof 41
The Patient|May 11, 2021
Correction to: Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference StudyA Cecilia Jimenez-Moreno, Eline van Overbeeke, Cathy Anne Pinto, et al.
The Lancet. Oncology|October 25, 2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-upMeredith M Regan, Patrick Neven, Anita Giobbie-Hurder, et al.
Scientific Reports|March 3, 2016
N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and NeprilysinA Ian Smith, Niwanthi W Rajapakse, Oded Kleifeld, et al.
Nature Communications|July 7, 2023
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancersEugene F Schuster, Elena Lopez-Knowles, Anastasia Alataki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in SequenceJacquie H Chirgwin, Anita Giobbie-Hurder, Alan S Coates, et al.
Scientific Reports|April 23, 2016
Corrigendum: N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and NeprilysinA Ian Smith, Niwanthi W Rajapakse, Oded Kleifeld, et al.
Zookeys|February 5, 2019
Acari of CanadaFrédéric Baulieu, Wayne Knee, Victoria Nowell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) TrialIan Smith, Denise Yardley, Howard Burris, et al.
Neurosurgical Review|January 8, 2026
Comparison of two novel options for resuspension of inverted U-shaped nasopharyngeal flap following endonasal access to cranio-vertebral junction: Pilot cadaveric analysis and illustrative case reportBeatrice Zucca, Marissa Koscielski, John Na, et al.
Nature Communications|October 5, 2021
Orchestrating and sharing large multimodal data for transparent and reproducible researchAnthony Mammoliti, Petr Smirnov, Minoru Nakano, et al.
Pageof 41